Compare SHIP & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SHIP | ARCT |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.0M | 194.1M |
| IPO Year | 2007 | N/A |
| Metric | SHIP | ARCT |
|---|---|---|
| Price | $9.45 | $6.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | $11.00 | ★ $38.67 |
| AVG Volume (30 Days) | 201.0K | ★ 706.5K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | ★ 8.04% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.75 | N/A |
| Revenue | ★ $150,354,000.00 | $97,601,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $9.68 | N/A |
| P/E Ratio | $12.65 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.78 | $5.85 |
| 52 Week High | $11.15 | $24.17 |
| Indicator | SHIP | ARCT |
|---|---|---|
| Relative Strength Index (RSI) | 43.47 | 34.10 |
| Support Level | $9.22 | $6.34 |
| Resistance Level | $9.80 | $6.75 |
| Average True Range (ATR) | 0.27 | 0.39 |
| MACD | -0.14 | 0.12 |
| Stochastic Oscillator | 14.49 | 2.30 |
Seanergy Maritime Holdings Corp is an international shipping company that provides marine dry bulk transportation services through the ownership and operation of dry bulk vessels. It generates a majority of its revenue from the vessels. The company's fleet of vessels includes Blueship, Meiship, Kaizenship, Iconship, Titanship, Flagship, Paroship, Worldship, Hellasship, Partnership, Championship, Patriotship, Dukeship, Honorship, Fellowship, Knightship, Lordship, Premiership, Squireship, and Friendship.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.